265 related articles for article (PubMed ID: 14642780)
1. Lipopolysaccharide activates Akt in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through nuclear factor-kappa B activation.
Hattori Y; Hattori S; Kasai K
Eur J Pharmacol; 2003 Nov; 481(2-3):153-8. PubMed ID: 14642780
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone suppresses iNOS gene expression by inhibiting NF-kappaB in vascular smooth muscle cells.
Matsumura M; Kakishita H; Suzuki M; Banba N; Hattori Y
Life Sci; 2001 Jul; 69(9):1067-77. PubMed ID: 11508649
[TBL] [Abstract][Full Text] [Related]
3. Hypertonicity inhibits lipopolysaccharide-induced nitric oxide synthase expression in smooth muscle cells by inhibiting nuclear factor kappaB.
Pingle SC; Sanchez JF; Hallam DM; Williamson AL; Maggirwar SB; Ramkumar V
Mol Pharmacol; 2003 Jun; 63(6):1238-47. PubMed ID: 12761333
[TBL] [Abstract][Full Text] [Related]
4. Cytokine-activated Jak-2 is involved in inducible nitric oxide synthase expression independent from NF-kappaB activation in vascular smooth muscle cells.
Doi M; Shichiri M; Katsuyama K; Ishimaru S; Hirata Y
Atherosclerosis; 2002 Jan; 160(1):123-32. PubMed ID: 11755929
[TBL] [Abstract][Full Text] [Related]
5. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-kappa B, CREB and C/EBP beta.
Hecker M; Preiss C; Schini-Kerth VB
Br J Pharmacol; 1997 Mar; 120(6):1067-74. PubMed ID: 9134219
[TBL] [Abstract][Full Text] [Related]
6. 4-hydroxynonenal prevents NO production in vascular smooth muscle cells by inhibiting nuclear factor-kappaB-dependent transcriptional activation of inducible NO synthase.
Hattori Y; Hattori S; Kasai K
Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1179-83. PubMed ID: 11451748
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of some cell signalling inhibitors upon nitric oxide synthase expression and nuclear factor-kappaB activation induced by lipopolysaccharide in rat aortic smooth muscle cells.
Zhou J; Struthers AD; Lyles GA
Pharmacol Res; 1999 May; 39(5):363-73. PubMed ID: 10328994
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclic GMP-dependent vasodilators on the expression of inducible nitric oxide synthase in vascular smooth muscle cells: role of cyclic AMP.
Boese M; Busse R; Mülsch A; Schini-Kerth V
Br J Pharmacol; 1996 Oct; 119(4):707-15. PubMed ID: 8904645
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide synthase in lipopolysaccharide- or cytokine-stimulated C6 glial cells.
Pahan K; Raymond JR; Singh I
J Biol Chem; 1999 Mar; 274(11):7528-36. PubMed ID: 10066820
[TBL] [Abstract][Full Text] [Related]
10. Heparin-binding epidermal growth factor-like growth factor inhibits cytokine-induced NF-kappa B activation and nitric oxide production via activation of the phosphatidylinositol 3-kinase pathway.
Mehta VB; Besner GE
J Immunol; 2005 Aug; 175(3):1911-8. PubMed ID: 16034135
[TBL] [Abstract][Full Text] [Related]
11. [The synergistic effect of interferon-gamma on the induction of nitric oxide synthase by lipopolysaccharide in vascular smooth muscle].
Hattori S
Nihon Naibunpi Gakkai Zasshi; 1995 Jan; 71(1):87-96. PubMed ID: 7534727
[TBL] [Abstract][Full Text] [Related]
12. N-alpha-tosyl-L-lysine chloromethylketone prevents expression of iNOS in vascular smooth muscle by blocking activation of NF-kappa B.
Schini-Kerth VB; Boese M; Busse R; Fisslthaler B; Mülsch A
Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):672-9. PubMed ID: 9108779
[TBL] [Abstract][Full Text] [Related]
13. Antioxidants differentially affect nuclear factor kappa B-mediated nitric oxide synthase expression in vascular smooth muscle cells.
Hecker M; Preiss C; Schini-Kerth VB; Busse R
FEBS Lett; 1996 Feb; 380(3):224-8. PubMed ID: 8601429
[TBL] [Abstract][Full Text] [Related]
14. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW
Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111
[TBL] [Abstract][Full Text] [Related]
15. Cytokine-activated p42/p44 MAP kinase is involved in inducible nitric oxide synthase gene expression independent from NF-kappaB activation in vascular smooth muscle cells.
Doi M; Shichiri M; Katsuyama K; Marumo F; Hirata Y
Hypertens Res; 2000 Nov; 23(6):659-67. PubMed ID: 11131279
[TBL] [Abstract][Full Text] [Related]
16. Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells.
Hattori Y; Nakanishi N; Kasai K
Cardiovasc Res; 2002 Jun; 54(3):649-58. PubMed ID: 12031711
[TBL] [Abstract][Full Text] [Related]
17. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
Katsuyama K; Shichiri M; Marumo F; Hirata Y
Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459
[TBL] [Abstract][Full Text] [Related]
18. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha.
Katsuyama K; Hirata Y
J Biochem; 2001 Apr; 129(4):585-91. PubMed ID: 11275558
[TBL] [Abstract][Full Text] [Related]
19. Regulation of lipopolysaccharide-induced inducible nitric-oxide synthase expression through the nuclear factor-kappaB pathway and interferon-beta/tyrosine kinase 2/Janus tyrosine kinase 2-signal transducer and activator of transcription-1 signaling cascades by 2-naphthylethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (THI 53), a new synthetic isoquinoline alkaloid.
Kim HJ; Tsoyi K; Heo JM; Kang YJ; Park MK; Lee YS; Lee JH; Seo HG; Yun-Choi HS; Chang KC
J Pharmacol Exp Ther; 2007 Feb; 320(2):782-9. PubMed ID: 17108235
[TBL] [Abstract][Full Text] [Related]
20. Growth factors enhance interleukin-1 beta-induced persistent activation of nuclear factor-kappa B in rat vascular smooth muscle cells.
Jiang B; Xu S; Brecher P; Cohen RA
Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1811-6. PubMed ID: 12426209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
